Julia Bonavitacola

Patients with early relapsing multiple sclerosis (MS) were able to switch to ocrelizumab after suboptimal responses to other disease-modifying therapies.

Interviews with patients living with generalized myasthenia gravis (MG) in the US revealed areas of increased burden in these patients.

Spending on health expenditures will make up 20.6% of gross domestic product, according to a federal report.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Lower rates of successful discharge were reported in home health care patients whose care was interrupted by flooding related to hurricanes.

Veligrotug-vvze (Lumvoa; Viridian Therapeutics) is the first treatment for thyroid eye disease that has been approved by the FDA.

There was no observed increase in risk to short- or mid-term clinically relevant infections despite the low levels of immunoglobulins.

Fraud, waste, and abuse are key areas that can affect strategies in care delivery and can undermine the ability to give quality care.Health care leaders

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Veligrotug is a newly FDA-approved treatment that can target the proptosis associated with thyroid eye disease.